Insider and congress filings
DexCom, Inc. (DXCM)
About DexCom, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Jacob Steven Leach
- Employees
- 11,050
- Listed since
- Apr 14, 2005
- Market value
- $31.7B
- Price to earnings
- 32.4
- Earnings per share
- $2.61
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | $0.70 | $0.61 | $1.3B | $1.3B | EPS beatRevenue in line |
| Q1 FY2026reported Apr 30, 2026 | $0.56 | $0.47 | $1.2B | $1.2B | EPS beatRevenue in line |
| Q4 FY2025reported Feb 12, 2026 | $0.68 | $0.65 | $1.3B | $1.2B | EPS beatRevenue in line |
| Q3 FY2025reported Oct 30, 2025 | $0.61 | $0.58 | $1.2B | $1.2B | EPS beatRevenue beat |
| Q2 FY2025reported Jul 30, 2025 | $0.48 | $0.44 | $1.2B | $1.1B | EPS beatRevenue beat |
| Q1 FY2025reported May 1, 2025 | $0.32 | $0.33 | $1.0B | $1.0B | EPS missRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Apr 15, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Kevin SayerExecutive Chairman | $1.2M | $13.9M | $1.2M | $16.3M |
| Jacob LeachPresident & Chief Executive Officer | $769K | $5.9M | $1.3M | $8.0M |
| Jereme SylvainEVP, Chief Financial Officer | $647K | $5.9M | $495K | $7.1M |
| Jon ColemanEVP, Chief Commercial Officer | $492K | $5.8M | $423K | $6.7M |
| Michael BrownEVP, Chief Legal Officer | $632K | $5.2M | $470K | $6.3M |
| Sadie SternEVP, Chief Human Resources Officer | $571K | $5.2M | $439K | $6.3M |
The summary compensation table from the 2025 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $2.6B | 38,244,137 | -1.8% | 9.97% |
| Vanguard Capital Management LLC | $1.7B | 25,209,752 | +0.8% | 6.57% |
| Vanguard Portfolio Management LLC | $1.3B | 19,656,540 | +2.3% | 5.12% |
| State Street Corp | $1.2B | 18,380,806 | +2.5% | 4.79% |
| Invesco Ltd. | $1.0B | 15,288,133 | +89.3% | 3.98% |
| Baillie Gifford & Co | $996.9M | 14,801,590 | -5.1% | 3.86% |
| Geode Capital Management, LLC | $834.2M | 12,426,515 | +0.6% | 3.24% |
| UBS Asset Management Americas Inc | $758.5M | 11,261,876 | +15.6% | 2.94% |
| Alliancebernstein L.P. | $734.3M | 11,693,409 | -9.5% | 3.05% |
| Wellington Management Group LLP | $574.3M | 8,527,471 | -8.6% | 2.22% |
| Arrowstreet Capital, Limited Partnership | $462.9M | 6,873,273 | +170.1% | 1.79% |
| Norges Bank | $462.6M | 6,868,090 | +100.0% | 1.79% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
20 filings of 366 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Sadie SternEVP Chief People & Culture Off | Sold | 2,565 | $88.37 | $227K | Aug 27, 2026 | 1d |
| Kevin R. SayerExecutive Chair | Sold · 3 lines | 26,756 | $90.01 | $2.4M | Aug 20, 2026 | 4d |
| Michael Jon BrownEVP Chief Legal Compliance Off | Sold | 1,700 | $91.93 | $156K | Aug 14, 2026 | 3d |
| Bridgette P. HellerDirector | Sold | 1,012 | $88.29 | $89K | Aug 12, 2026 | 1d |
| Mark G. FolettaDirector | Sold | 2,000 | $80.00 | $160K | Jul 31, 2026 | 4d |
| Mark G. FolettaDirector | Sold | 2,000 | $85.32 | $171K | Aug 3, 2026 | 1d |
| Kevin R. SayerExecutive Chair | Sold | 26,756 | $76.32 | $2.0M | Jul 20, 2026 | 1d |
| Michael Jon BrownEVP Chief Legal Compliance Off | Sold | 1,700 | $74.42 | $127K | Jul 15, 2026 | 1d |
| Kevin R. SayerExecutive Chair | Sold | 26,756 | $72.00 | $1.9M | Jul 6, 2026 | 1d |
| Mark G. FolettaDirector | Sold · 2 lines | 4,000 | $74.13 | $297K | Jun 15, 2026 | 2d |
| Michael Jon BrownEVP Chief Legal Compliance Off | Sold | 1,700 | $75.55 | $128K | Jun 15, 2026 | 2d |
| Jon ColemanEVP, Chief Commercial Officer | Sold | 4,912 | $73.00 | $359K | Jun 3, 2026 | 2d |
| Jon ColemanEVP, Chief Commercial Officer | Sold | 4,911 | $74.13 | $364K | Jun 4, 2026 | 1d |
| Kevin R. SayerExecutive Chair | Sold | 26,759 | $72.00 | $1.9M | May 21, 2026 | 5d |
| Michael Jon BrownEVP, Chief Legal Officer | Sold | 1,700 | $59.91 | $102K | May 15, 2026 | 4d |
| Bridgette P. HellerDirector | Sold | 1,012 | $60.01 | $61K | May 12, 2026 | 2d |
| Michael Jon BrownEVP, Chief Legal Officer | Sold | 1,700 | $63.04 | $107K | Apr 15, 2026 | 1d |
| Michael Jon BrownEVP, Chief Legal Officer | Sold | 1,700 | $64.85 | $110K | Mar 16, 2026 | 2d |
| Bridgette P. HellerDirector | Sold | 1,012 | $68.01 | $69K | Feb 12, 2026 | 5d |
| Richard Alexander CollinsDirector | Sold | 2,906 | $59.05 | $172K | Nov 14, 2025 | 3d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in DXCM
20 disclosures of 113 on record · median 18d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +24.5%S&P +2.1% · vs S&P 500 +22.5% | Jun 30, 2026 | Jul 6, 2026 | 6d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | +38.3%S&P +4.4% · vs S&P 500 +33.9% | May 7, 2026 | Jun 10, 2026 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +36.1%S&P +3.2% · vs S&P 500 +33.0% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +36.7%S&P +5.8% · vs S&P 500 +30.9% | May 1, 2026 | Jun 9, 2026 | 39d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +19.4%S&P +1.6% · vs S&P 500 +17.8% | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +32.9%S&P +11.1% · vs S&P 500 +21.8% | Apr 13, 2026 | May 11, 2026 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +36.2%S&P +6.8% · vs S&P 500 +29.5% | Apr 24, 2026 | May 11, 2026 | 17d |
| Tina SmithSpouse | Stock | Sale (Partial) | $100,001 - $250,000 | +45.7%S&P +7.1% · vs S&P 500 +38.6% | Apr 29, 2026 | May 10, 2026 | 11d |
| Tina SmithSpouse | Stock | Sale (Full) | $100,001 - $250,000 | +37.7%S&P +4.2% · vs S&P 500 +33.5% | May 7, 2026 | May 10, 2026 | 3d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +35.5%S&P +20.7% · vs S&P 500 +14.9% | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +28.2%S&P +16.5% · vs S&P 500 +11.7% | Mar 23, 2026 | Apr 7, 2026 | 15d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | +18.9%S&P +11.3% · vs S&P 500 +7.7% | Feb 4, 2026 | Mar 10, 2026 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +21.0%S&P +13.0% · vs S&P 500 +8.0% | Feb 5, 2026 | Mar 9, 2026 | 32d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +19.1%S&P +11.6% · vs S&P 500 +7.5% | Feb 17, 2026 | Mar 9, 2026 | 20d |
| John BoozmanJoint | Stock | Purchase | $1,001 - $15,000 | +14.4%S&P +10.0% · vs S&P 500 +4.4% | Jan 26, 2026 | Feb 15, 2026 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +13.4%S&P +9.8% · vs S&P 500 +3.5% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | +19.3%S&P +11.4% · vs S&P 500 +7.8% | Oct 27, 2025 | Nov 10, 2025 | 14d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +21.2%S&P +14.2% · vs S&P 500 +7.0% | Sep 22, 2025 | Oct 10, 2025 | 18d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +26.2%S&P +14.9% · vs S&P 500 +11.3% | Sep 29, 2025 | Oct 3, 2025 | 4d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | +10.3%S&P +20.8% · vs S&P 500 -10.5% | Aug 7, 2025 | Sep 11, 2025 | 35d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
3 members · estimate, as of Sep 10, 20263 members report a position (estimated). The largest estimated position is in the $250,001 - $500,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Tina Smith | Democrat · Senate | $250,001 - $500,000 | 14.0% |
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.1% |
| John Boozman | Republican · Senate | $1,001 - $15,000 | 0.3% |
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Jacob Steven LeachPresident, CEO, and Director | Tax withholding | 1,451 | Aug 22, 2026 |
| Sadie SternEVP Chief People & Culture Off | Tax withholding | 1,451 | Aug 22, 2026 |
| Michael Jon BrownEVP Chief Legal Compliance Off | Tax withholding | 1,451 | Aug 22, 2026 |
| Jereme M. SylvainEVP, Chief Financal Officer | Tax withholding | 1,451 | Aug 22, 2026 |
| Nicholas AugustinosDirector | Gift | 1,075 | Aug 12, 2026 |
| Steven R. AltmanDirector | Stock award | 5,565 | May 28, 2026 |
| Kyle MaladyDirector | Stock award | 5,575 | May 28, 2026 |
| Nicholas AugustinosDirector | Stock award | 5,575 | May 28, 2026 |
| Renee D. GalaDirector | Stock award | 5,605 | May 28, 2026 |
| Richard Alexander CollinsDirector | Stock award | 5,605 | May 28, 2026 |
| Euan A. AshleyDirector | Stock award | 5,565 | May 28, 2026 |
| Mark G. FolettaDirector | Stock award | 6,331 | May 28, 2026 |
| Bridgette P. HellerDirector | Stock award | 5,575 | May 28, 2026 |
| Albert Frederick Osterloh IVDirector | Stock award | 1,630 | May 28, 2026 |
| Rimma DriscollDirector | Stock award | 5,605 | May 28, 2026 |
| Jon ColemanEVP, Chief Commercial Officer | Tax withholding | 7,362 | May 22, 2026 |
| Jacob Steven LeachPresident, CEO, and Director | Tax withholding | 1,451 | May 22, 2026 |
| Michael Jon BrownEVP Chief Legal Compliance Off | Tax withholding | 1,451 | May 22, 2026 |
| Jereme M. SylvainEVP, Chief Financal Officer | Tax withholding | 1,451 | May 22, 2026 |
| Sadie SternEVP Chief People & Culture Off | Tax withholding | 1,451 | May 22, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling DXCM?
Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales.
Which members of Congress have traded DXCM?
Ro Khanna, Michael T. McCaul, Tina Smith, John Boozman disclosed DXCM transactions in the filings shown here.
Which members of Congress hold DXCM?
3 members of Congress report a position in DXCM in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to Tina Smith, Robert Bresnahan and John Boozman. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is DXCM in the S&P 500 or the Nasdaq 100?
DexCom, Inc. is a current member of the S&P 500 and Nasdaq 100, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are DXCM trades disclosed?
Insider filings on this page reached the public a median of 2 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 18 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.